Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Aaron Alt"


2 mentions found


Aug 15 (Reuters) - Drug distributor Cardinal Health Inc (CAH.N) on Tuesday raised fiscal 2024 expectations for sales at its pharmaceutical unit, banking on growing demand for newer weight-loss drugs, including GLP-1 treatments. Cardinal peers AmerisourceBergen (ABC.N) and McKesson (MCK.N) have also flagged a potential boost to revenues for drug distributors due to high demand for these drugs. It now expects revenue from its pharmaceuticals unit to rise 10% to 12% in fiscal 2024, compared with its previous expectation of about 10% growth. It raised its 2024 profit forecast slightly to a range of $6.50 to $6.75 per share, from $6.45 to $6.70 it had forecast previously. Excluding one-off items, Cardinal Health reported a profit of $1.55 per share in the fourth quarter ended June 30, topping expectations of $1.49 per share.
Persons: Novo, Eli Lilly's, it's, Cardinal, AmerisourceBergen, Aaron Alt, Vaibhav Sadhamta, Mariam Sunny, Pooja Desai Organizations: Health Inc, Cardinal Health, Thomson Locations: United States, Bengaluru
Cardinal Health Hires Finance Chief From Sysco
  + stars: | 2022-12-19 | by ( Dean Seal | ) www.wsj.com   time to read: 1 min
Cardinal Health Inc. has hired Aaron Alt, the chief financial officer of Sysco Corp. , to be its next finance chief. The Dublin, Ohio-based healthcare-products distributor said Monday that Mr. Alt will take over from Trish English, who has served as interim finance chief since August when then-CFO Jason Hollar was tapped as chief executive officer. Mr. Alt will succeed Ms. English on Feb. 10, the company said. Mr. Alt has been with Sysco since December 2020, according to his LinkedIn profile. He previously served as CFO for Sally Beauty Holdings Inc. and held senior executive roles at Target Corp. Write to Dean Seal at dean.seal@wsj.comCopyright ©2022 Dow Jones & Company, Inc. All Rights Reserved.
Total: 2